These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3987778)

  • 1. Relationship between lipid composition and drug metabolizing capacity of human liver.
    Savolainen MJ; Arranto AJ; Hassinen IE; Luoma PV; Pelkonen RO; Sotaniemi EA
    Eur J Clin Pharmacol; 1985; 27(6):727-32. PubMed ID: 3987778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phenobarbital upon triacylglycerol metabolism in the rabbit.
    Goldberg DM; Roomi MW; Yu A; Roncari DA
    Biochem J; 1980 Oct; 192(1):165-75. PubMed ID: 7305894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
    Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary lipid on drug-metabolizing enzymes.
    Wade AE; Norred WP
    Fed Proc; 1976 Nov; 35(13):2475-9. PubMed ID: 824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phenobarbital upon triacylglycerol metabolism in the guinea pig.
    Goldberg DM; Yu A; Roomi MW; Roncari DA
    Can J Biochem; 1981 Jan; 59(1):48-53. PubMed ID: 6112053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.
    Luoma PV; Sotaniemi EA; Pelkonen RO; Arranto A; Ehnholm C
    Eur J Clin Pharmacol; 1982; 23(3):275-82. PubMed ID: 7173298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.
    Farrell GC; Cooksley WG; Powell LW
    Clin Pharmacol Ther; 1979 Oct; 26(4):483-92. PubMed ID: 487696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver size and indices of drug metabolism in alcoholics.
    Pirttiaho HI; Sotaniemi EA; Ahlqvist J; Pitkänen U; Pelkonen RO
    Eur J Clin Pharmacol; 1978 Mar; 13(1):61-7. PubMed ID: 639835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triacylglycerol metabolism in the phenobarbital-treated rat.
    Goldberg DM; Roomi MW; Yu A; Roncari DA
    Biochem J; 1981 Apr; 196(1):337-46. PubMed ID: 7306075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.
    Luoma PV; Savolainen MJ; Sotaniemi EA; Pelkonen RO; Arranto AJ; Ehnholm C
    Acta Med Scand; 1983; 214(2):103-9. PubMed ID: 6624542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450-phospholipid requirement.
    Kaschnitz RM; Coon MJ
    Biochem Pharmacol; 1975 Jan; 24(2):295-7. PubMed ID: 1111541
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
    Rikans LE; Notley BA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):574-8. PubMed ID: 7062268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
    Sotaniemi EA; Pelkonen RO; Puukka M
    Eur J Clin Pharmacol; 1980 Apr; 17(4):267-74. PubMed ID: 6105079
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug metabolism in man: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Ahlqvist J; Hokkanen OT
    Arch Toxicol Suppl; 1978; (1):339-42. PubMed ID: 277127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
    Spaethe SM; Jollow DJ
    Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study on the effect of vigabatrin on in vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers.
    Bartoli A; Gatti G; Cipolla G; Barzaghi N; Veliz G; Fattore C; Mumford J; Perucca E
    Epilepsia; 1997 Jun; 38(6):702-7. PubMed ID: 9186253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.
    Salmela PI; Sotaniemi EA; Pelkonen RO
    Diabetes; 1980 Oct; 29(10):788-94. PubMed ID: 7439538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.